<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
     xmlns:admin="http://webns.net/mvcb/"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:content="http://purl.org/rss/1.0/modules/content/"
     xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>JoriPress &#45; zenovel pharma</title>
<link>https://joripress.com/rss/author/zenovel-pharma</link>
<description>JoriPress &#45; zenovel pharma</description>
<dc:language>en</dc:language>
<dc:rights>Copyright © 2025 JoriPress &#45; All Rights Reserved</dc:rights>

<item>
<title>FDA’s New Charcoal BE Expectation for Inhalation Generics: Is Your Development Strategy Ready?</title>
<link>https://joripress.com/fdas-new-charcoal-be-expectation-for-inhalation-generics-is-your-development-strategy-ready</link>
<guid>https://joripress.com/fdas-new-charcoal-be-expectation-for-inhalation-generics-is-your-development-strategy-ready</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202603/image_870x580_69ba8e2c421e1.webp" length="25750" type="image/jpeg"/>
<pubDate>Wed, 18 Mar 2026 14:36:22 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>U.S. Food and Drug Administration Approach to Nitrosamine Control: Innovative Solutions for Drug Safety and Compliance</title>
<link>https://joripress.com/us-food-and-drug-administration-approach-to-nitrosamine-control-innovative-solutions-for-drug-safety-and-compliance</link>
<guid>https://joripress.com/us-food-and-drug-administration-approach-to-nitrosamine-control-innovative-solutions-for-drug-safety-and-compliance</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_699c2a69a0d3c.webp" length="18418" type="image/jpeg"/>
<pubDate>Mon, 23 Feb 2026 13:27:43 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>ROI of GMP Audits: Cost vs Compliance Risk</title>
<link>https://joripress.com/roi-of-gmp-audits-cost-vs-compliance-risk</link>
<guid>https://joripress.com/roi-of-gmp-audits-cost-vs-compliance-risk</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_698708e232f17.webp" length="22722" type="image/jpeg"/>
<pubDate>Fri, 20 Feb 2026 14:47:59 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Comprehensive GMP &amp;amp; Regulatory Compliance Services in USA: Strengthening Quality, Compliance, and Inspection Readiness</title>
<link>https://joripress.com/comprehensive-gmp-regulatory-compliance-services-in-usa-strengthening-quality-compliance-and-inspection-readiness</link>
<guid>https://joripress.com/comprehensive-gmp-regulatory-compliance-services-in-usa-strengthening-quality-compliance-and-inspection-readiness</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_6995a01e0e23d.webp" length="38028" type="image/jpeg"/>
<pubDate>Wed, 18 Feb 2026 14:24:01 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Why GCP Compliance and Independent Monitoring Are Critical for Clinical Trial Success</title>
<link>https://joripress.com/why-gcp-compliance-and-independent-monitoring-are-critical-for-clinical-trial-success</link>
<guid>https://joripress.com/why-gcp-compliance-and-independent-monitoring-are-critical-for-clinical-trial-success</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_6992ebf14a809.webp" length="27534" type="image/jpeg"/>
<pubDate>Mon, 16 Feb 2026 13:10:03 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Third&#45;Party GMP Audits: Benefits &amp;amp; When to Use Them</title>
<link>https://joripress.com/third-party-gmp-audits-benefits-when-to-use-them</link>
<guid>https://joripress.com/third-party-gmp-audits-benefits-when-to-use-them</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_698708e232f17.webp" length="22722" type="image/jpeg"/>
<pubDate>Sat, 07 Feb 2026 12:42:04 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Internal vs External GMP Audits: Which One Do You Need?</title>
<link>https://joripress.com/internal-vs-external-gmp-audits-which-one-do-you-need</link>
<guid>https://joripress.com/internal-vs-external-gmp-audits-which-one-do-you-need</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_698477de266c2.webp" length="18992" type="image/jpeg"/>
<pubDate>Thu, 05 Feb 2026 13:59:35 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Overview on Bayesian Methods and Their Growing Importance in Clinical Trials</title>
<link>https://joripress.com/overview-on-bayesian-methods-and-their-growing-importance-in-clinical-trials</link>
<guid>https://joripress.com/overview-on-bayesian-methods-and-their-growing-importance-in-clinical-trials</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_69832d169f3ed.webp" length="30840" type="image/jpeg"/>
<pubDate>Wed, 04 Feb 2026 14:27:56 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Bioequivalence Studies for Complex Generics: Key Concepts Explained</title>
<link>https://joripress.com/bioequivalence-studies-for-complex-generics-key-concepts-explained</link>
<guid>https://joripress.com/bioequivalence-studies-for-complex-generics-key-concepts-explained</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202602/image_870x580_69805af8ecec8.webp" length="36256" type="image/jpeg"/>
<pubDate>Mon, 02 Feb 2026 11:09:07 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Pre&#45;Submission Regulatory Affairs: The Key to Successful FDA PAIs</title>
<link>https://joripress.com/pre-submission-regulatory-affairs-the-key-to-successful-fda-pais</link>
<guid>https://joripress.com/pre-submission-regulatory-affairs-the-key-to-successful-fda-pais</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202601/image_870x580_697de6a3c1151.webp" length="27490" type="image/jpeg"/>
<pubDate>Sat, 31 Jan 2026 14:25:44 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

<item>
<title>Regulatory Affairs in 2026: Key Trends Shaping Pharma &amp;amp; Biotech</title>
<link>https://joripress.com/regulatory-affairs-in-2026-key-trends-shaping-pharma-biotech</link>
<guid>https://joripress.com/regulatory-affairs-in-2026-key-trends-shaping-pharma-biotech</guid>
<description><![CDATA[  ]]></description>
<enclosure url="https://joripress.com/uploads/images/202601/image_870x580_6979ceedf0f10.webp" length="64776" type="image/jpeg"/>
<pubDate>Wed, 28 Jan 2026 11:59:08 +0300</pubDate>
<dc:creator>zenovel pharma</dc:creator>
<media:keywords></media:keywords>
</item>

</channel>
</rss>